Search KLH Site
Find Articles by Tags
Addiction (18) Adjuvant - Alum (1) Adjuvant - GPI-0100 (1) Adjuvant - IL-4 (9) Adjuvant GM-CSF (16) Adjuvant KLH (4) Adjuvant Oil / Surfactant (4) Adjuvant QS-21 (25) Age & Physical Activity (3) Allergen-specific immunotherapy (1) Allergy – Pollen (2) Alzheimer's Disease (3) Antibody Response (35) Antibody Response IgA (14) Antibody Response IgE (6) Antibody Response IgG (106) Antibody Response IgM (71) Antibody Response IgY (1) APEC (1) Assay - Bioassay (2) Assay - Carbohydrate Microarray (1) Assay - ELISA (55) Assay - ELISPOT (7) Assay - Immunoassay (8) Assay - InVitro (18) Assay - InVivo (1) Atopic Dermatitis (1) Autoimmune Disease (1) B-epitope (1) Bone Marrow Transplant (6) Cancer (6) Cancer - Bladder (16) Cancer - Brain & CNS (8) Cancer - Breast (15) Cancer - Cervical (1) Cancer - Colorectal (10) Cancer - Esophageal (1) Cancer - Female Reproductive (7) Cancer - Leukemia (2) Cancer - Lung (4) Cancer - Lymphoma (25) Cancer - Melanoma (37) Cancer - Mesothelioma (1) Cancer - Myeloma (15) Cancer - Other (2) Cancer - Ovarian (3) Cancer - Pancreas (1) Cancer - Pediatric (3) Cancer - Peritoneal (2) Cancer - Prostate (9) Cancer - Renal (13) Cancer - Sarcoma (2) Clostridium difficile (5) Crohn's Disease (2) Cross-Reactive Antigens (6) Delayed-type hypersensitivity response (1) Dendritic Cell (66) Developmental (10) Diabetes (2) Disease Resistence (1) DNP-Ficoll (2) DTH (67) Environmental (15) Escherichia coli (1) Fingolimod (Gilenya) (1) Healthy Volunteers (18) HealthyAntibody Response - IgA (1) Hepatitis (2) HIV (11) HPV (3) Husbandry (3) Hypertension (1) id-KLH (29) IL 1 (4) IL 12 (2) IL 15 (1) IL 2 (10) IL 5 (1) IL 6 (1) IL 7 (1) Immune Disease - Autoimmune (13) Immune Disease - Primary (2) Immune Disease – Secondary (1) Immune Response - Cellular (187) Immune Response - Humoral (259) Immune Response Humoral (2) Immunotoxicity (37) Infection (1) Infectious Disease (5) Inflammatory Disease (1) Intradermal KLH (1) Kidney (1) KLH-BEC2 (1) KLH-BP16 (1) KLH-BPO (1) KLH-Conjugate (69) KLH-EGFR (2) KLH-FITC (1) KLH-Ganglioside (16) KLH-Globo H (7) KLH-GM2 (1) KLH-hD1 (1) KLH-HGP-30 (1) KLH-IL (1) KLH-Kinoid (8) KLH-Lewis Y (3) KLH-MUC (8) KLH-Oxycodone (2) KLH-sTn (9) KLH-TF (5) KLH-TN (3) Model - Canine (6) Model - Guinea Pig (10) Model - Livestock (10) Model - Mouse (73) Model - Other (32) Model - Primate (12) Model - Rat (51) Multiple Sclerosis (1) Nasal (3) Natrural Antibody (1) Neonatal (2) NK Cells (1) NSAID (1) Oral KLH (9) Oxycodone (3) Parasitic Disease (6) Pediatric (1) Plant-made (2) PLNA (1) Population Density (3) Psoriasis (1) Review Article (2) Rheumatoid Arthritis (11) Rituximab (Rituxan) (4) Russian thistle (1) Sal k 1 (1) Stress (8) Systemic Lupus Erythematosus (SLE) (7) TACA (2) TDAR (127) Therapeutics - KLH Alone (15) Transplant (6) Ultra Violet radiation (1) Uveitis (1) VEGF (3) Veterinary (1)
Terms and Privacy

KLH in Publications

Publications of scientific research involving KLH. Abstracts or full text articles are available by link to outside sites. If you know of a KLH-related publication that is not yet on KLH Site™, let us know.

(in order by date)

Entries in Cancer - Brain & CNS (8)

Monday
Oct312016

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma.

Fenstermaker RACiesielski MJQiu JYang NFrank CLLee KPMechtler LRBelal AAhluwalia MSHutson AD

Cancer Immunol Immunother. 2016 Nov;65(11):1339-1352. Epub 2016

Saturday
Dec052015

Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer

Mayu O Frank, Julia Kaufman, Salina Parveen, Nathalie E Blachère, Dana E Orange, and Robert B Darnell

J Transl Med. 2014; 12: 338.
Published online 2014 Dec 5. doi:  10.1186/s12967-014-0338-3

 

Relates to Clinical Trials:
NCT00289341NCT00345293, and NCT00893945

 

Monday
Nov032014

The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients

Michelle Paff, Daniela Alexandru-Abrams, Frank P K Hsu, and Daniela A Bota.

Published online 2015 Jan 27. doi:  10.4161/21645515.2014.983002

 

 

Monday
Jul012013

Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

Vidyalakshmi Chandramohan, Duane A Mitchell, Laura A Johnson, John H Sampson, and Darell D Bigner.

Future Oncol. 2013 July; 9(7): 977-990.

 

Friday
Nov302012

Phase I Peptide Vaccine With Montanide ISA-51 VG in Children With Refractory Central Nervous System (CNS) Tumors

Sharon Gardner1, Rachel Sabado1, Genevieve Legault1, David Zagzag2, Krysten Brown1, Crystal Cruz1, Farah Hasan1, Martin Jadus3, Isabelita Vengco1, Nina Bhardwaj1.

1 NYU Cancer Institute, New York University Langone Medical Center, New York, NY;
2 Pathology, New York University Langone Medical Center, New York, NY;
3 Pathology and Laboratory Medicine Service, VA Long Beach Healthcare System, Long Beach, CA.

Abstracts for the 27th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC);  J Immunotherapy, Vol. 35, No. 9, November–December 2012

Saturday
Aug012009

The PEP-3-KLH (CDX-110) vaccine in glioblastoma multiforme patients

Amy B. Heimberger, MD and John H Sampson, MD, PhD.

Expert Opin Biol Ther. 2009 August; 9(8): 1087–1098

Sunday
Nov302008

Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines

Schmittling RJ, Archer GE, Mitchell DA, Heimberger A, Pegram C, Herndon JE 2nd, Friedman HS, Bigner DD, Sampson JH.

J Immunol Methods. 2008 Nov 30;339(1):74-81. Epub 2008 Sep 4

Saturday
Nov012008

Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors.

Suminoe A, Matsuzaki A, Hattori H, Koga Y, Hara T.

Pediatr Transplant. Epub 2008 Nov 1.  2009 Sep;13(6):746-53.